Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: SPAG6 hypermethylation silences a novel tumor suppressor and inhibits renal cell carcinoma progression via PI3K/AKT/mTOR pathway

  • Tianyu Wu,
  • Xing Ji,
  • Yongyang Yun,
  • Xiaofei Wang,
  • Ying Gan,
  • Yu Fan,
  • Qian Zhang

There are errors in the author affiliations. The correct affiliations are as follows:

Tianyu Wu 1,2,3,4, Xing Ji 1,2,3,4, Yongyang Yun 1,2,3,4, Xiaofei Wang 5, Ying Gan 1,2,3,4, Yu Fan 1,2,3,4, Qian Zhang 1,2,3,4,6

1 Department of Urology, Peking University First Hospital, Beijing, China, 2 Institution of Urology, Peking University, Beijing, China, 3 Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing, China, 4 National Urological Cancer Center, Beijing, China, 5 Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China, 6 Department of Urology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

Reference

  1. 1. Wu T, Ji X, Yun Y, Wang X, Gan Y, Fan Y, et al. SPAG6 hypermethylation silences a novel tumor suppressor and inhibits renal cell carcinoma progression via PI3K/AKT/mTOR pathway. PLoS One. 2025;20(10):e0333202. pmid:41042741

Citation: Wu T, Ji X, Yun Y, Wang X, Gan Y, Fan Y, et al. (2026) Correction: SPAG6 hypermethylation silences a novel tumor suppressor and inhibits renal cell carcinoma progression via PI3K/AKT/mTOR pathway. PLoS One 21(3): e0345024. https://doi.org/10.1371/journal.pone.0345024

Published: March 13, 2026

Copyright: © 2026 Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.